C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
260/327.7
C07D 327/02 (2006.01)
Patent
CA 1208653
ABSTRACT OF THE DISCLOSURE Novel 6H-dibenz [b,e][1,4] oxathiepin deriva- tives of the formulae I and IA are employed in the treatment and control of allergic conditions such as allergic asthma. Image Image I IA wherein n is an integer of from 1-4; Z is thio, sulfinyl, or sulfonyl; R1, R2 and R3 are each independently se- lected from hydrogen, halogen, amino, Cl to C4 alkyl, Cl to C4 alkylthio, Cl to C4 alkylsulfinyl, Cl to C4 alkylsulfonyl, trifluoromethyl, trifluoromethylthio, cyano, nitro, and Cl to C4 alkyl or dialkylamino, Cl to C4 alkoxy, Cl to C4 alkanoyl, aralkyl, or hydroxy Cl to C4 alkyl; R4 is H, Cl to C4 acyl, Cl to C4 alkylamino- acyl, Cl to C4 alkylcarboxy, Cl to C4 alkylcarboxamido, Cl to C4 alkylcarboxamidoacyl or Cl to C4 acyloxy Cl to C4 alkyl; R1 and R2 can also be an unsubstituted C2 to C6 polymethylene chain, or said chain is substituted with a hydroxy or keto group.
437651
Hamel Pierre
Rokach Joshua
Goudreau Gage Dubuc
Merck Frosst Canada & Co./merck Frosst Canada & Cie
LandOfFree
6h-dibenz [b,e] [1,4] oxathiepin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6h-dibenz [b,e] [1,4] oxathiepin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6h-dibenz [b,e] [1,4] oxathiepin derivatives will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1179213